76 related articles for article (PubMed ID: 26308232)
1. Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis.
Pergialiotis V; Pitsouni E; Prodromidou A; Frountzas M; Perrea DN; Vlachos GD
Menopause; 2016 Mar; 23(3):335-42. PubMed ID: 26308232
[TBL] [Abstract][Full Text] [Related]
2. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence.
Col NF; Kim JA; Chlebowski RT
Breast Cancer Res; 2005; 7(4):R535-40. PubMed ID: 15987460
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Underweight Status on the Prognosis of Ovarian Cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer patients and hormone replacement therapy: a systematic review.
Hopkins ML; Fung MF; Le T; Shorr R
Gynecol Oncol; 2004 Mar; 92(3):827-32. PubMed ID: 14984948
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
8. Maintenance chemotherapy for ovarian cancer.
Mei L; Chen H; Wei DM; Fang F; Liu GJ; Xie HY; Wang X; Zou J; Han X; Feng D
Cochrane Database Syst Rev; 2010 Sep; (9):CD007414. PubMed ID: 20824860
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials.
Wu L; Ma D; Walton-Moss B; He Z
Menopause; 2014 Jan; 21(1):89-99. PubMed ID: 23736858
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
Wu YS; Shui L; Shen D; Chen X
Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
[TBL] [Abstract][Full Text] [Related]
12. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials.
Yang B; Shi W; Yang J; Liu H; Zhao H; Li X; Jiao S
Breast; 2013 Apr; 22(2):150-157. PubMed ID: 23298851
[TBL] [Abstract][Full Text] [Related]
13. TRADITIONAL CHINESE MEDICINE COMBINED WITH HORMONE THERAPY TO TREAT PREMATURE OVARIAN FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
Kou MJ; Ding XF; Chen JX; Liu Y; Liu YY
Afr J Tradit Complement Altern Med; 2016; 13(5):160-169. PubMed ID: 28487907
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Kong A; Johnson N; Kitchener HC; Lawrie TA
J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
[TBL] [Abstract][Full Text] [Related]
15. Effects of lifestyle modification on cancer recurrence, overall survival and quality of life in gynaecological cancer survivors: A systematic review and meta-analysis.
Yeganeh L; Harrison C; Vincent AJ; Teede H; Boyle JA
Maturitas; 2018 May; 111():82-89. PubMed ID: 29673836
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials.
Casanova G; Bossardi Ramos R; Ziegelmann P; Spritzer PM
J Clin Endocrinol Metab; 2015 Mar; 100(3):1028-37. PubMed ID: 25514104
[TBL] [Abstract][Full Text] [Related]
17. Effects of ovarian ablation or suppression in premenopausal breast cancer: A meta-analysis of randomized controlled trials.
Zhang P; Li CZ; Jiao GM; Zhang JJ; Zhao HP; Yan F; Jia SF; Hu BS; Wu CT
Eur J Surg Oncol; 2017 Jul; 43(7):1161-1172. PubMed ID: 28024943
[TBL] [Abstract][Full Text] [Related]
18. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.
Chlebowski RT; Pan K; Col NF
Breast Cancer Res Treat; 2017 Jan; 161(2):185-190. PubMed ID: 27785653
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
Del Mastro L; Ceppi M; Poggio F; Bighin C; Peccatori F; Demeestere I; Levaggi A; Giraudi S; Lambertini M; D'Alonzo A; Canavese G; Pronzato P; Bruzzi P
Cancer Treat Rev; 2014 Jun; 40(5):675-83. PubMed ID: 24360817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
